Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trans fat disclosure study proposed

This article was originally published in The Tan Sheet

Executive Summary

FDA submits for Office of Management & Budget review a proposed experimental study to evaluate whether trans-fat disclosures will help consumers choose healthier foods. The proposal follows a July 2003 advance notice of proposed rulemaking requesting comments about possible fatty-acids disclosure requirements to accompany nutrient content claims. FDA says the study will evaluate how such disclosure requirements would sway consumers' choices, with the results providing empirical support for possible policy decisions about requiring disclosures and determining how the information would be formatted on packages. "Experimental manipulation of labels...makes it possible to estimate the effects of various possible disclosure requirements while controlling for individual differences," the agency says. Comments are due 30 days from the proposal's publication in the Federal Register Dec. 15...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel